Literature DB >> 29130078

Hepatic Adaptations to a High Fat Diet in the MRL Mouse Strain are Associated with an Inefficient Oxidative Phosphorylation System.

Ahlke Heydemann1,2, Magdalis González-Vega1, Tirsit K Berhanu1, Aaron J Mull1, Ragav Sharma1, Jenan Holley-Cuthrell1.   

Abstract

The MRL mice are resistant to a 12-week high fat diet (HFD) feeding protocol, with the proximal cause being an increased basal pAMPKT172 expression in the skeletal muscle. Here, we test if this lack of pathology extends to the liver at both the tissue and cellular levels and its correlation to pAMPKT172 levels. MRL and B6 mice were subjected to 12 weeks of diet intervention and tissues were either fixed for histology or snap-frozen for further processing (n= 3-6, per group). The HFD MRL mice remain insulin and glucose sensitive after 12 weeks of HFD. This phenomenon is correlated to increased liver pAMPKT172. The HFD-fed B6 control strain demonstrates the opposite trend with decreased pAMPKT172 expression after the HFD period. We have found further evidence of differential MRL metabolic adaptations. These differences include reduced glycogen content, reduced ectopic fat storage, and increased expression of Complex II (CII) and Complex V of the Electron Transport Chain (ETC). Whereas, B6 HFD control show unchanged glycogen content, increased ectopic fat and increased expression of Complex I and Complex V of the ETC. Taken together, the MRL adaptations point to an inefficient energy-producing phenotype that leads to glycogen depletion and attenuation of ectopic fat as secondary consequences with AMPK as the signaling mediator of these HFD- hepatic adaptations.

Entities:  

Keywords:  AMPK; MRL mice; glycogen; high fat diet; liver; oxidative phosphorylation; steatosis

Year:  2016        PMID: 29130078      PMCID: PMC5681357     

Source DB:  PubMed          Journal:  Jacobs J Diabetes Endocrinol        ISSN: 2475-4900


  44 in total

1.  Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.

Authors:  P Shah; A Vella; A Basu; R Basu; W F Schwenk; R A Rizza
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 2.  Metformin pathways: pharmacokinetics and pharmacodynamics.

Authors:  Li Gong; Srijib Goswami; Kathleen M Giacomini; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-11       Impact factor: 2.089

Review 3.  AMPK: positive and negative regulation, and its role in whole-body energy homeostasis.

Authors:  D Grahame Hardie
Journal:  Curr Opin Cell Biol       Date:  2014-09-26       Impact factor: 8.382

Review 4.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

5.  The super super-healing MRL mouse strain.

Authors:  Ahlke Heydemann
Journal:  Front Biol (Beijing)       Date:  2012-12-01

6.  The Murphy Roths Large (MRL) mouse strain is naturally resistant to high fat diet-induced hyperglycemia.

Authors:  Aaron J Mull; Tirsit K Berhanu; Nathan W Roberts; Ahlke Heydemann
Journal:  Metabolism       Date:  2014-09-26       Impact factor: 8.694

Review 7.  Attention to Background Strain Is Essential for Metabolic Research: C57BL/6 and the International Knockout Mouse Consortium.

Authors:  Danielle A Fontaine; Dawn Belt Davis
Journal:  Diabetes       Date:  2016-01       Impact factor: 9.461

8.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

9.  The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor.

Authors:  Andrew McBride; Stephanos Ghilagaber; Andrei Nikolaev; D Grahame Hardie
Journal:  Cell Metab       Date:  2009-01-07       Impact factor: 27.287

10.  Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells.

Authors:  Simon A Hawley; Fiona A Ross; Graeme J Gowans; Priyanka Tibarewal; Nicholas R Leslie; D Grahame Hardie
Journal:  Biochem J       Date:  2014-04-15       Impact factor: 3.857

View more
  1 in total

1.  Time-Dependent Changes in Hepatic Sphingolipid Accumulation and PI3K/Akt/mTOR Signaling Pathway in a Rat Model of NAFLD.

Authors:  Klaudia Sztolsztener; Karolina Konstantynowicz-Nowicka; Ewa Harasim-Symbor; Adrian Chabowski
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.